Culture models of human mammary epithelial cell transformation

J Mammary Gland Biol Neoplasia. 2000 Oct;5(4):365-78. doi: 10.1023/a:1009525827514.


Human pre-malignant breast diseases, particularly ductal carcinoma in situ (DCIS) already display several of the aberrant phenotypes found in primary breast cancers, including chromosomal abnormalities, telomerase activity, inactivation of the p53 gene, and overexpression of some oncogenes. Efforts to model early breast carcinogenesis in human cell cultures have largely involved studies of in vitro transformation of normal finite lifespan human mammary epithelial cells (HMEC) to immortality and malignancy. We present a model of HMEC immortal transformation consistent with the known in vivo data. This model includes a recently described, presumably epigenetic process, termed conversion, which occurs in cells that have overcome stringent replicative senescence and are thus able to maintain proliferation with critically short telomeres. The conversion process involves reactivation of telomerase activity, and acquisition of good uniform growth in the absence and presence of TGFbeta. We propose that overcoming the proliferative constraints set by senescence, and undergoing conversion, represent key rate-limiting steps in human breast carcinogenesis, and occur during early stage breast cancer progression.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Breast Neoplasms / genetics*
  • Breast Neoplasms / pathology
  • Cell Transformation, Neoplastic
  • Cells, Cultured
  • Cellular Senescence
  • DNA-Binding Proteins
  • Disease Models, Animal
  • Epithelial Cells / cytology*
  • Humans
  • Mammary Glands, Human / cytology*
  • Models, Biological
  • Phenotype
  • Telomerase / metabolism
  • Time Factors
  • Transforming Growth Factor beta / metabolism
  • Tumor Suppressor Protein p53 / physiology


  • DNA-Binding Proteins
  • Transforming Growth Factor beta
  • Tumor Suppressor Protein p53
  • Telomerase